AbbVie

AbbVie is a global, research-based biopharmaceutical company which combines the focus of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. AbbVie is committed to using unique approaches to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases.

Boehringer Ingelheim

Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.

Learn more at www.boehringer-ingelheim.us

Pfizer

Pfizer Corporate Responsibility believes that all individuals, everywhere, deserve access to quality healthcare and the opportunity to lead healthy lives. We combine traditional philanthropic methods with novel approaches that create an enduring and meaningful impact on public-health systems to facilitate access to healthcare for under-served communities around the world.

Novartis

Our mission at Novartis is to discover new ways to improve and extend people’s lives. We use science-based innovation to address some of society’s most challenging healthcare issues and develop breakthrough treatments, and find new ways to deliver them to as many people as possible.

UCB

At UCB, patients are at the heart of everything we do. Since UCB was established in the U.S. in 1994, the U.S. affiliate of UCB has continuously maintained invaluable programs for patients, healthcare professionals, caregivers and patient communities. Many of the programs we support are noted for their innovative and pioneering work in healthcare.

Johnson & Johnson

Johnson & Johnson Innovative Medicine is leading where medicine is going. Our goal is to restore health for all patients with immune-mediated diseases.  Patients inform and inspire our science-based innovations, which continue to change and save lives. With a relentless commitment to developing innovative and effective treatments, we confidently address the most complex diseases of our time and unlock the potential medicines of tomorrow.  Our diverse portfolio spans multiple therapeutic areas—Oncology, Immunology, Neuroscience, Cardiopulmonary, and Specialty ophthalmology.

Mallinckrodt Pharmaceuticals

Mallinckrodt is a global business that develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. To learn more visit www.mallinckrodt.com.

Aurinia Pharma

Aurinia Pharmaceuticals is a late-stage clinical biopharmaceutical company focused on developing therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. The Company is currently developing an investigational drug for the treatment of lupus nephritis. The Company’s head office is in Victoria, British Columbia, its U.S. commercial hub in Rockville, Maryland, and focuses its development efforts globally.

Bristol Myers Squibb

Bristol Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases.

GlaxoSmithKline

GlaxoSmithKline is a science-led global healthcare company with a mission to help people do more, feel better, live longer. We research, manufacture and make available a broad range of medicines, vaccines and consumer healthcare products. Visit our exhibit for information about our products and resources.

Lilly

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded in 1876 by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission. To learn more, visit www.lilly.com.